Sachs disease) in mouse brains upon engraftment of transduced progenitor
cells. Nat. Med. 2:424–429. 45.
26. Lilly, F. 1967. Susceptibility to two strains of Friend leukemia virus in mice.
Science 155:461–462.
27. Lipton, S. A. 1992. Requirement for macrophages in neuronal injury induced
by HIV envelope protein gp120. Neuroreport 3:913–915.
28. Lynch, W. P., W. J. Brown, G. J. Spangrude, and J. L. Portis. 1994. Microglia 46.
infection by a neurovirulent murine retrovirus results in defective processing
of envelope protein and intracellular budding of virus particles. J. Virol.
68:3401–3409. 47.
29. Lynch, W. P., S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991.
Murine retrovirus-induced spongiform encephalopathy: productive infection
of microglia and cerebellar neurons in accelerated CNS disease. Neuron
7:365–379. 48.
30. Lynch, W. P., and J. L. Portis. 1993. Murine retrovirus-induced spongiform
encephalopathy: disease expression is dependent on postnatal development
of the central nervous system. J. Virol. 67:2601–2610.
31. Lynch, W. P., S. J. Robertson, and J. L. Portis. 1995. Induction of focal 49.
spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J. Virol. 69:1408–1419. 50.
32. Masuda, M., M. P. Remington, P. M. Hoffman, and S. K. Ruscetti. 1992.
Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211. J. Virol. 66:2798–
51.
2806.
33. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild
mouse neurotropic retrovirus: detection of comparable levels of virus repli-52.
cation in mouse strains susceptible and resistent to paralytic disease. J. Virol.
56:1010–1022.
34. Michaels, J., R. W. Price, and M. K. Rosenblum. 1988. Microglia in the giant
53.
cell encephalitis of acquired immune deficiency syndrome: proliferation,
infection and fusion. Acta Neuropathol. 76:373–379.
54.
35. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell
lines to avoid recombination leading to helper virus production. Mol. Cell.
Biol. 6:2895–2902.
55.
36. Morey, M. K., and C. A. Wiley. 1990. Immunohistochemical localization of
the neurotropic ecotropic murine leukemia virus in moribund mice. Virology
178:104–112.
37. Nagra, R. M., P. G. Burrola, and C. A. Wiley. 1992. Development of spon-56.
giform encephalopathy in retroviral infected mice. Lab. Invest. 66:292–302.
38. Oldstone, M. B. A., F. Jensen, F. J. Dixon, and P. W. Lampert. 1980.
Pathogenesis of the slow disease of the central nervous system associated
with the wild mouse virus. II. Role of virus and host gene products. Virology 57.
107:180–193.
39. Oldstone, M. B. A., P. W. Lampert, S. Lee, and F. J. Dixon. 1977. Pathogenesis of the slow disease of the central nervous system associated with WM
1504 E virus. Am. J. Pathol. 88:193–212. 58.
40. Paquette, Y., Z. Hanna, P. Savard, R. Brousseau, Y. Robitaille, and P.
Jolicoeur. 1989. Retrovirus-induced murine motor neuron disease: mapping 59.
the determinant of spongiform degeneration within the envelope gene. Proc.
Natl. Acad. Sci. USA 86:3896–3900.
41. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly 60.
accelerated by long terminal repeat and gag-pol sequences from nondefective
Friend murine leukemia virus. J. Virol. 64:1648–1656.
42. Portis, J. L., S. Perryman, and F. J. McAtee. 1991. The R-U5-5' leader
sequence of neurovirulent wild mouse retrovirus contains an element con- 61.
trolling the incubation period of neurodegenerative disease. J. Virol. 65:
1877–1883.
43. Price, J., D. L. Turner, and C. L. Cepko. 1987. Lineage analysis in the
vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. 62.
Acad. Sci. USA 84:156–160.
Priola, S. A., B. Caughey, R. E. Race, and B. Chesebro. 1994. Heterologous
PrP molecules interfere with accumulation of protease-resistant PrP in
